Workflow
RedHill Biopharma Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer
Prnewswire· 2025-07-02 00:00
Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored by ANZUP, and supported by Bayer and Ramsay Hospital Research FoundationPrecision medicine approach: The 60-patient Phase 2 study uses the PCPro™ lipid biomarker test to identify patients with poor prognosis most likely to benefit from the combinationLed by Professor Lisa Horvath, the study is expected to recruit people at sites across Australia and New ZealandProstate cancer is the s ...
Anterix: Wide Spectrum Coverage And Robust Balance Sheet To Justify Upside
Seeking Alpha· 2025-07-01 23:59
As one of the largest specialized spectrum holders of private LTE networks across the US, Anterix, Inc. (NASDAQ: ATEX ) continues to enjoy its domestic popularity and market presence. Its strong performance in recent quarters demonstrates its ability toI have been working in the logistics sector for almost two decades. I have been into stock investing and macroeconomic analysis for almost a decade. Currently, I focus on ASEAN and NYSE/NASDAQ Stocks, particularly in banks, telco, logistics, and hotels. Since ...
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Petco Health and Wellness Company, Inc. (WOOF)
GlobeNewswire News Room· 2025-07-01 23:58
NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of all persons or entities who purchased or otherwise acquired Petco Health and Wellness Company, Inc. (“Petco” or the “Company”) (NASDAQ: WOOF) securities between January 14, 2021 and June 5, 2025, both dates inclusive (the “Class Period”). The Complaint alleges that Defendants made false a ...
Green Dot Corporation: A Lot To Unpack
Seeking Alpha· 2025-07-01 23:56
We run the investing group The Insiders Forum where we specialize in small and mid-cap stocks that insiders are buying. The Insiders Forum portfolio managed by Bret Jensen consists of 12-25 top stocks in different sectors of the market that are attractively valued and have had some significant and recent insider purchases. Our goal is to outperform the Russell 2000 (the benchmark) over time. Analyst's Disclosure:I/we have a beneficial long position in the shares of GDOT either through stock ownership, optio ...
HOOD Launches Tokenized Stocks in EU: Betting on Digital Asset Boom?
ZACKS· 2025-07-01 23:56
Key Takeaways Robinhood now offers tokenized U.S. stocks and ETFs to EU clients with zero commissions and 24/5 access. HOOD's crypto DARTs jumped 66.7% in May 2025, signaling rising investor activity and demand. HOOD's EU expansion, Bitstamp and WonderFi deals, and MiCA pursuits deepen its crypto ecosystem.Robinhood Markets, Inc. (HOOD) has introduced U.S. stock and exchange-traded fund (ETF) tokens for European Union (EU) investors. This will enable eligible HOOD clients to gain exposure to U.S. equities ...
Biogen Begins Phase III Felzartamab Study for Third Kidney Disease
ZACKS· 2025-07-01 23:50
核心观点 - Biogen启动felzartamab治疗原发性膜性肾病(PMN)的全球III期研究 预计2029年公布顶线数据 [1] - felzartamab是抗CD38抗体 针对PMN具有独特作用机制 目前该疾病尚无获批疗法 [1] - 公司通过收购Human Immunology Biosciences获得felzartamab管线 该药物最初由MorphoSys AG开发 [2] 研究设计 - III期PROMINENT研究将比较felzartamab与他克莫司在180例中高风险PMN患者中的疗效 [3][4] - 主要终点为第104周达到蛋白尿完全缓解的患者比例 同时评估血清aPLA2R抗体水平和患者报告结果 [5] - 研究将根据患者抗PLA2R抗体水平进行分组 [5] 疾病背景 - PMN是一种严重肾脏疾病 可导致肾衰竭 美国约3.6万患者 [6] - 当前治疗依赖免疫抑制剂或化疗 约三分之一患者治疗失败 [6] 其他研究进展 - 2025年公司还启动felzartamab在肾移植抗体介导排斥反应(IgA肾病)的III期研究 [7] - 此前II期研究显示 多数患者aPLA2R抗体水平一周内中位下降45% 六个月后超50%下降 [10] - 安全性方面主要为轻度至中度输注相关反应 [11] 公司表现 - 公司股价年内下跌17.9% 跑输行业3.6%的跌幅 [3] 行业比较 - Immunocore年内股价上涨6.4% 2025年每股亏损预估从1.57美元改善至0.86美元 [13] - Verona Pharma股价年内飙升103.7% 2025年每股收益预估从亏损0.07美元转为盈利0.22美元 [14] - Agenus股价年内大涨66.8% 2025年每股收益预估从亏损4.66美元转为盈利1.56美元 [15]
Does Joby Aviation's Milestone in Dubai Point Toward Further Growth?
ZACKS· 2025-07-01 23:45
Key Takeaways JOBY jumped after piloted eVTOL flights in Dubai, marking a milestone in its push toward commercialization. JOBY plans to develop facilities capable of producing up to 500 eVTOL aircraft annually in Dayton. JOBY stock is up 29.8% YTD, outperforming its industry despite trading at a premium price-to-book valuation.Shares of Joby Aviation (JOBY) , a leading player in the electric vertical takeoff and landing (eVTOL) space, gained in double digits on June 30 following the announcement that its ...
3 Dates for Disney Investors to Circle in July After the Stock Hit New Highs in June
The Motley Fool· 2025-07-01 23:45
A new and an updated attraction hope to keep turnstile clicks coming at both domestic resorts with a new Marvel movie hoping to keep Disney's stock upticks coming. culminates in riders in six-passenger cars circling around the attraction building at speeds up to nearly 65 miles per hour. It is introducing some features that will give a nod to the original and more tranquil World of Motion attraction that opened in the same space when the park opened in 1982. Shares of Walt Disney (DIS -0.79%) enter July wit ...
Equinix Clobbered On Analyst Day
Seeking Alpha· 2025-07-01 23:43
Analyst day events are a great opportunity to gain a better understanding of a company's direction. They often feature multi-year outlooks and deeper discussion of business strategy than would be available in shorter form content or quarterly reports. The magnitude of content drop often has a big effect on market price, and data center giant Equinix (NASDAQ:EQIX) was no exception. SA Equinix dropped from over $900 to just over $700 in the hours and days following their analyst day event. This article will e ...
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Petco Health and Wellness Company, Inc. (WOOF) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
GlobeNewswire News Room· 2025-07-01 23:43
ATLANTA, July 01, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Petco Health and Wellness Company, Inc. (“Petco” or the “Company”) (NASDAQ: WOOF). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information about Petco’s business, operations, and prospects, including allegations that: (i) Petco’s pandemic-related tailwinds were unsustainable, as was its business model of selling primarily p ...